Showing 1 - 10 of 19
From its 1958 origin in defense, the Advanced Research Projects Agency (ARPA) model for research funding has, in the last two decades, spread to other parts of the US federal government with the goal of developing radically new technologies. In this paper, we propose that the key elements of the...
Persistent link: https://www.econbiz.de/10012916916
The National Institute of Health (NIH), through its extramural grant program, is the primary public funder of health-related research in the United States. Peer review at NIH is organized around the twin principles of investigator initiation and rigorous peer review, and this combination has...
Persistent link: https://www.econbiz.de/10013066024
Persistent link: https://www.econbiz.de/10009553538
Persistent link: https://www.econbiz.de/10010490192
Persistent link: https://www.econbiz.de/10011545151
Persistent link: https://www.econbiz.de/10011882112
Persistent link: https://www.econbiz.de/10010340498
Scientific projects that carry a high degree of risk may be more likely to lead to breakthroughs yet also face challenges in winning the support necessary to be carried out. We analyze the determinants of renewal for more than 100,000 R01 grants from the National Institutes of Health between...
Persistent link: https://www.econbiz.de/10015326488
We quantify the impact of scientific grant funding at the National Institutes of Health (NIH) on patenting by pharmaceutical and biotechnology firms. Our paper makes two contributions. First, we use newly constructed bibliometric data to develop a method for flexibly linking specific grant...
Persistent link: https://www.econbiz.de/10013029543
We quantify the impact of scientific grant funding at the National Institutes of Health (NIH) on patenting by pharmaceutical and biotechnology firms. Our paper makes two contributions. First, we use newly constructed bibliometric data to develop a method for flexibly linking specific grant...
Persistent link: https://www.econbiz.de/10012457777